VEDANTA: CO PROMOTERS LOOKING TO INCREASE STAKE IN VEDANTA AT RS 350/SHARE || JPMORGAN IS ACTING AS BROKER TO TWIN STAR HOLDINGS AND VEDANTA NETHERLANDS INVESTMENT BV (PURCHASER) ON THE PURCHASE OF EQUITY SHARES OF VEDANTA - CNBCTV18

#Lauruslab #ImmunoACT potential

CAR T-cells are genetically engineered T-cells which is used in immunotherapy in developed nations for cancer treatment

ImmunoACT is first to develop this in the country. It started phase I/II trials in Jun-21 in India for blood cancer patient

Any chart is not working in this sharp fall down.

So there is no chart available.

#staytuned.
#stayupdated.

Keep an eye

Anything can happen today, another big fall, even bigger than yesterday, or we can also see good recovery today.
Be ready with your SL orders in the system. Don't let the market give you bigger losses than you can afford.
Many opportunities will come in the weeks coming ahead, then we'll buy and make profits again.
This is how the market works.

Escorts keep an eye for upgraded target 🙏

DISCLAIMER: IT'S MY VIEWS ONLY FOR EDUCATIONAL PURPOSE, NOT ANY RECOMMENDATION, I'M NOT A SEBI REGISTERED RESEARCH ANALYST. I AM NOT RESPONSIBLE FOR YOUR PROFIT OR LOSS. PLEASE CONSULT YOUR FINANCIAL ADVISOR BEFORE TAKING ANY DECISIONS.
@candlesticksRB

Raymond 525 soon can hit target 3 in weak markets showing good strength

Vedanta all target done n dusted 🚀🙏🚀🙏👍🙏

Raymond in blasting mode 567 3rd target done, ready for target 4 now🙏🚀🔥🔥🔥🔥🚀🚀🚀

Personally holding Raymond will sell by today patience holder can hold for 600+soon

Birla soft 499.90 ,500 done now ready for 550 soon 🚀🔥🙏

Target upgraded to 500/550
Now birla soft
TIMEFRAME - 1week

Nov 17call date blasted in a week